Kathryn Ries Tringale
@KathrynTringale
Radiation oncologist at UCSD specializing in CNS and Heme malignancies
ID:1368198884556746756
06-03-2021 13:56:53
38 Tweets
86 Followers
50 Following
In Journal of the @NCCN - we analyzed #medicare data to estimate usage patterns for hypofractionated #radiotherapy for elderly pts with 🧠 tumors and found interesting differences in use by site of care. Great work with Kathryn Ries Tringale Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center
doi.org/10.6004/jnccn.…
I'm so pleased to share that work led by
Kathryn Ries Tringale on the 'Prognostic Implications of SCLC Transcriptional Subtyping for CNS Mets' is online at JCO Precision Oncology (ascopubs.org/doi/full/10.12…)!
Memorial Sloan Kettering Radiation Oncology
Memorial Sloan Kettering Cancer Center
New at #AACR24 : Drs Jonathan Yang & Brandon Imber present research on a new tx for GBM --study drug AZD1390 & #radiotherapy .
Dr Imber: “I think this is a promising and novel therapeutic combination for one of the most difficult-to-treat cancers.” 🧠☢️
mskcc.org/news/aacr-2024…
☢️🧠Neurosurgery Publications: This Memorial Sloan Kettering Cancer Center retrospective review of 102 consecutive pts treated with spine reirradiation. In pts with extensive disease involvement, re #SBRT of spine metastases with 40 Gy in 5 fractions seems to be safe & effective.
journals.lww.com/neurosurgery/f…
New by PGY2 Dr Nikhil Mankuzhy, MD with Dr Suzanne Wolden: Re-irradiation with hypofractionation for locally recurrent diffuse intrinsic pontine glioma #DIPG achieved survival duration comparable to published outcomes & effectively palliated symptoms. #pedcsm
onlinelibrary.wiley.com/doi/10.1002/pb…
New in JTO & JTO CRR from Dr Brandon Imber:
Intracranial response to #osimertinib is excellent for pts with #EGFR -mutant #NSCLC #lcsm with de novo, previously untx brain metastases. Low local failure rates support upfront osimertinib alone in selected pts.
sciencedirect.com/science/articl…
This study led by Dr Suzanne Wolden Memorial Sloan Kettering Cancer Center is the largest, most recent analysis of the efficacy & safety of #IORT in #pedcsm pts with relapsed or refractory #neuroblastoma . It shows IORT is an effective & safe technique to achieve local control. sciencedirect.com/science/articl…
🙏Please share with your networks, Escape Stupid Cancer Elephants and Tea Triage Cancer Cancer and Careers 13thirty Cancer Connect Teen Cancer America b-present Cactus Cancer Society (Lacuna Loft) Adolescent & Young Adult Cancer Alliance
➡️ redcap.mskcc.org/surveys/?s=J73… (3/3)
Genomic analysis of 233 non-small cell #LungCancer patients with #BrainMetastasis reveals distinct mutational patterns
#CancerResearch by @Dr_Luke_Pike The Pike Lab Henry Walch Kathryn Ries Tringale Anna Skakodub Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center
Cancer at Nature Portfolio nature.com/articles/s4146…
New research in Nature Communications from The Pike Lab, Niki Schultz & team describe the genomics and clinical outcomes of a large set of patients with #NSCLC brain metastasis. The findings could help guide future treatment decisions. nature.com/articles/s4146…
New study on #AYAs & #financialtoxicity ! 🚨💰(Memorial Sloan Kettering Cancer Center Fumiko Ladd Chino, MD) #lymsm #ayacsm
➡️redcap.mskcc.org/surveys/?s=J73… (1/3)
Survivors of #HodgkinLymphoma can face difficult treatment decisions & financial tradeoffs. We want to better understand how cancer (and cancer-related costs) have affected your life so that we can provide better resources in the future. #lymsm #ayacsm
🙏redcap.mskcc.org/surveys/?s=J73…
🚨🚨Brain RT can affect fine motor skills (FMS) ✍️📱 & 🖐️👁️coordination. But can we PREVENT it? YES! ➡️Check out our lab’s latest from 🔥Dr. Mike Connor: 1st NTCP study of FMS using multivariate approach & prospective data #btsm #survivorship #functionalpreservation 1/🧵
It's a Match! Welcome to Memorial Sloan Kettering Cancer Center #radonc !! 🥳
🙌Kathryn Hockemeyer MD, PhD
🙌Gideon Haber, MD
🙌Elisa Liu, MD
🙌Revathi Ravella, MD
🙌Alexander Terry, MD
🙌Shoshana Rosenzweig, MD
We're excited to have you join us in New York!
#Match2023 #radonc Match2023